NASDAQ:ALNY   Alnylam Pharmaceuticals, Inc
Current price is unattractive, expecting a lot of investors to cash out.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.